Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Lacosamide 100 mg Film-Coated Tablets vs VIMPAT 100 mg in Thai Healthy Volunteers (Fasting)
TCTR20260620007Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lacosamide (2 arms), sponsored by Bio-innova. Primary endpoint: Primary pharmacokinetic bioequivalence. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
lacosamide
Beyond the preview
Go deeper on TCTR20260620007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260620007.